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ABSTRACT  
Background: Undisturbed functioning of the blood-brain barrier (BBB) crucially depends on 
paracellular signaling between its associated cells; particularly endothelial cells, pericytes and 
astrocytes. Hypoxic and ischemic injuries are closely associated with disturbed BBB function 
and the contribution of perivascular cells to hypoxic/ischemic barrier regulation has gained 
increased attention. Regardless, detailed information on the basal hypoxic/ischemic 
responses of the barrier-associated cells is rare and the outcome of such cell-specific 
responses on BBB modulation is not well understood. This study investigated crucial 
parameters of hypoxic/ischemic adaptation in order to characterize individual perivascular cell 
responses to stress conditions.   
Methods: The brain microvascular endothelial cell line RBE4 (EC cell line) as well as primary 
rat brain endothelial cells (ECs), pericytes (PCs) and astrocytes (ACs) were exposed to 24 
and 48 hours of oxygen deprivation at 1% and 0.2% O2. All primary cells were additionally 
subjected to combined oxygen and glucose deprivation mimicking ischemia. Central 
parameters of cellular adaptation and state, such as HIF-1α and HIF-1 target gene induction, 
actin cytoskeletal architecture, proliferation and cell viability, were compared between the cell 
types.  
Results: We showed that endothelial cells exhibit greater responsiveness and sensitivity to 
oxygen deprivation than ACs and PCs. This higher sensitivity coincided with rapid and 
significant stabilization of HIF-1α and its downstream targets (VEGF, GLUT-1, MMP-9 and 
PHD2), early disruption of the actin cytoskeleton and strong metabolic impairment in 
conditions where the perivascular cells remained largely unaffected. Additional adaptation 
(suppression) of proliferation also likely contributes to astrocytic and pericytic tolerance during 
severe injury conditions. Moreover, unlike the perivascular cells, ECs were incapable of 
inducing autophagy (monitored via LC3-II and Beclin-1 expression) - a putative protective 
mechanism. Notably, both ACs and PCs were significantly more susceptible to glucose than 
oxygen deprivation with ACs proving to be most resistant overall.  
Conclusion: In summary this work highlights considerable differences in sensitivity to 
hypoxic/ischemic injury between microvascular endothelial cells and the perivascular cells. 
This can have marked impact on barrier stability. Such fundamental knowledge provides an 
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important foundation to better understand the complex cellular interactions at the BBB both 
physiologically and in injury-related contexts in vivo. 
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BACKGROUND 
Brain neurons require a stable environment and high nutrient supply for proper functioning [1]. 
In this regard, the well-coordinated teamwork of the cells at the blood-brain barrier (BBB) is 
indispensable. Endothelial cells that line barrier vessels have intimate contact with supporting 
pericytes and astrocytes, as well as microglia, neurons and a well-defined extracellular matrix 
to fulfill their gatekeeper function at the BBB, crucially controlling nutrient supply and 
homeostatic balance [2]. It has become very apparent that these endothelial cells depend on 
inductive signaling of the surrounding cell types to fully develop and maintain their unique 
barrier phenotype [3, 4]. Recently the important contribution of perivascular astrocytes and 
pericytes to BBB induction and maintenance has received increasing attention (for review see 
[5]).  
Hypoxia (reduced tissue oxygenation) severely impairs BBB function in vivo and in vitro [6-8] 
causing pathophysiological changes including disturbed energy balance and water/ion 
homeostasis [5], inflammatory events and leakage of blood-proteins into the brain [5]. 
Similarly ischemia, being characterized by impaired nutrient and O2 supply, also results in 
significant BBB breakdown [9, 10]. Clearly, during injury conditions specific responses of 
astrocytes and pericytes impact BBB maintenance and brain function. Both astrocytes and 
pericytes have been shown to support barrier function via tight junction retention and 
reduction of endothelial cell death under hypoxic conditions [6, 11-14]. On the contrary, both 
cell types up-regulate barrier permeabilizing factors in response to hypoxia/ischemia such as 
vascular endothelial growth factor (VEGF), cytokines, and matrix metalloproteinases (MMPs) 
[15]. Currently we do not understand well how, or from where, the differential signals that alter 
BBB characteristics originate, although some evidence suggests that injury severity and 
duration determines the functional outcome of hypoxic/ischemic insults on BBB tightness [5, 
16, 17]. In this regard hypoxia-inducible factor 1 (HIF-1), a central regulator of 
hypoxic/ischemic responses, is of particular importance. HIF-1 constitutes a heterodimeric 
transcription factor composed of the hypoxia-inducible HIF-1α subunit and the constitutively 
expressed HIF-1β subunit [18]. HIF-1 mediates hypoxic adaptation through transcriptional 
control of more than 100 genes participating in angiogenesis, proliferation and cellular 
metabolism to reduce O2 consumption and increase O2 supply but can also trigger cell death 
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[18, 19]. Notably, the ability of different cell types to adapt to hypoxic/ischemic stress varies 
considerably. Neurons for example are very sensitive to such insults, whereas other brain 
cells such as astrocytes are far more resistant [1]. Our previous study showed that astrocytes 
and pericytes differentially modulate BBB permeability at varying severities of hypoxic insults 
[6], implying that insult severity likely triggers individual cell-specific responses with 
subsequent consequences on barrier modulation.  
To gain better knowledge of cell-specific behavior in terms of overall tolerance as well as 
potential signaling to surrounding cells, we directly compared basal responses of individual 
BBB associated cells (brain microvascular endothelial cell line and primary rat endothelial 
cells (ECs), pericytes (PCs) and astrocytes (ACs)) to hypoxic and ischemic insults in vitro. We 
analyzed different parameters that influence hypoxic and ischemic responses including HIF-
1α stabilization and target gene expression, actin cytoskeletal alterations, proliferation, and 
cell survival. Notably the responsiveness and tolerance of the three cell types differed 
considerably and likely underlies their ability to maintain and/or modulate BBB integrity. 
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MATERIAL AND METHODS 
Cell culture and isolation of primary cells 
All cell culture media and reagents were obtained from Gibco® (Life Technologies, Zug, 
Switzerland). A rat brain endothelial cell line, RBE4 (EC cell line) [20] was cultivated from 
passage 35-45 in 1:1 α-MEM/Ham’s F-10 medium mixture supplemented with 10% FBS, 300 
µg/ml geneticin, and 1 ng/ml basic fibroblast growth factor (Pepro Tech, Rocky Hill, NJ, USA) 
on rat tail collagen coated petri dishes. Rat tail collagen was isolated as described in Roll et 
al. [21]. Primary rat brain endothelial cells (primary ECs) were isolated from 8-10 week old 
male Wistar rats according to Coisne et al. [22], with slight modifications. Isolated cortices 
were homogenized after removal of meninges in a 40 ml Dounce homogenizer. Microvessels 
were isolated from the homogenate by adding an equal volume of 30% Dextran solution and 
subsequent centrifugation at 3000 g for 25 min at 4°C. The microvessels were then filtered 
through a 60 µm nylon mesh to remove larger vessels and digested in HBSS buffer 
supplemented with 10 mM HEPES, 0.1% BSA, 2 mg/ml collagenase-dispase, 10 µg/ml 
DNAse I and 147 ng/ml TLCK, for 45 min at 37°C in a water bath. Digested microvessels 
were re-suspended in endothelial media (DMEM supplemented with 20% calf serum, BME 
amino acids, vitamin solution, 2 mM L-glutamine, 1 ng/ml bFGF, 50 µg/ml gentamycin sulfate) 
and plated on collagen-IV (Sigma-Aldrich)-coated culture dishes. One day after isolation 
primary ECs were treated with 3µg/ml puromycin-containing media for 24h to prevent pericyte 
contamination and then used in experiments on day 5 after isolation (i.e. without passaging). 
Primary rat astrocytes (ACs) were isolated from neonatal pups as described previously [23] 
and cultured in DMEM supplemented with 10% FBS and 50µg/ml gentamycin sulfate. Primary 
rat brain pericytes (PCs) were isolated from male adult rats following an established protocol 
[24] with slight modifications. Briefly, cortices were homogenized after removal of meninges. 
Subsequently microvessels were isolated by centrifugation (20 min at 3000 g at 4°C) using 
dextran (final concentration 16%) and digested in DMEM + 0.1% Collagenase/Dispase + 125 
ug/ml DNAse I (both Roche Diagnostics, Rotkreuz, Switzerland) in a water bath for 2h at 
37°C. After centrifugation (700 g, 5 min) freshly isolated pericytes were plated on rat tail 
collagen coated dishes and cultured in DMEM supplemented with 20% FBS, 50 µg/ml 
gentamycin sulfate and 2.5 µg/ml amphotericin B until confluency. Subsequent passages 
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were maintained on uncoated dishes in astrocyte medium. For all experiments astrocytes and 
pericytes were used at passage 2. The purity of all primary cultures was ≥95% as analyzed 
by immunostaining for standard cell markers namely GFAP (astrocytes), PECAM-1 
(endothelial cells), NG-2 (pericytes) & PDGFR-β (pericytes).  
 
Hypoxic and ischemic exposures 
O2 deprivation experiments were carried out in purpose-built hypoxic glove-box chambers 
(InVivO2 400, Ruskinn Technologies, Pencoed, UK) maintained at 37°C with 5% CO2. O2 
concentration was constantly monitored with an internal O2 sensor. Cells were exposed to 
hypoxia (1% O2) and near anoxia (0.2% O2) for up to 48h. Normoxic controls were maintained 
at 21% O2, 5% CO2 at 37°C. Ischemia was simulated in vitro by oxygen-glucose deprivation 
(OGD). OGD exposures were carried out on all primary cells under hypoxia and near anoxia 
using glucose-free media. 
 
Western blotting 
Cells were washed with ice-cold PBS and homogenized in cell lysis buffer (50 mM Tris, 150 
mM NaCl, 1% Triton X-100, 1% NP-40) supplemented with protease inhibitor cocktail 
(Calbiochem, Darmstadt, Germany), 1 mM sodium orthovanadate, 1 mM dithiothreitol, 0.5 
mM phenylmethansulfonyl fluoride and 1 mM EDTA. Protein concentration was determined 
with Pierce BCA protein assay (Thermo Fisher Scientific Inc., Rockford, IL, USA). Total 
proteins (20 µg) were separated on denaturing SDS-Page and transferred onto a 
nitrocellulose membrane. Membranes were blocked at room temperature in 5% non-fat dried 
milk or 5% BSA dissolved in Tris-buffered saline containing 0.1% Tween-20 and 
subsequently incubated overnight at 4°C with primary antibodies against β-actin (1:5000, 
Sigma–Aldrich, Buchs, Switzerland), α-tubulin (1:2000, Sigma–Aldrich), HIF-1α (1:1000, 
Novus Biologicals, Littleton, CO, USA), LC3 (1:2000, Novus Biologicals), Beclin-1 (1:250, 
Santa Cruz Biotech, Heidelberg, Germany), Bax (1:1000, Merck Milipore, Darmstadt, 
Germany) or BNIP3 (1:1000, Cell Signaling Technology, Leiden, The Netherlands). 
Membranes were washed with 0.1% Tween-20 in TBS then incubated with horseradish 
peroxidase conjugated secondary antibody (ImmunoResearch, Suffolk, UK). Band detection 
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was performed and visualized using a luminescent image analyzer LAS-3000 (Fujifilm, 
Dielsdorf, Switzerland). Blot quantification (using β-actin and α-tubulin as loading controls) 
was performed using ImageJ software (ImageJ, NIH, Bethesda, USA). 
 
Quantitative Real-time PCR 
Total RNA was isolated directly from culture dishes using TRIzol® Reagent (Life 
Technologies, Zug, Switzerland) according to the manufacturer`s description. One µg of RNA 
per sample was reverse transcribed using the ImProm-II ReverseTranscriptase kit (Promega, 
Dübendorf, Switzerland) according to the manufacturer’s instructions. For each cell type, a 
five-fold dilution series was prepared from the cDNA and standard curves were constructed 
separately for each target gene. PCR efficiencies were calculated from the standard curve 
slopes for all primer sets. This resulted in 90-100% efficiency for all targets measured. 
Furthermore, a single band of the expected size for each target, without primer dimers or off-
target amplifications, was confirmed by gel electrophoresis (data not shown). 
 Quantitative real-time PCR was performed with an ABI 7500 Fast Real-Time PCR System 
(Applied Biosystems, Zug, Switzerland) using Power Sybr® Green PCR Master Mix (Applied 
Biosystems). The following primers at 0.2µm final concentration were used: PHD2 5`-
AAGCCATGGTCGCCTGTTAC-3` and 5`-TGCGTACCTTGTGGCGTATG-3`, VEGF 5`-
CGCAAGAAATCCCGGTTTAA-3` and 5`-CAAATGCTTTCTCCGCTCTGA-3`, GLUT-1 5`-
GGGCATGATTGGTTCCTTCTC-3` and 5`-CAGGTTCATCATCAGCATGGA-3`, MMP-9 5`-
GGGAACGTATCTGGAAATTCGAC-3` and 5`-CCGGTTGTGGAAACTCACAC-3`, BNIP3 5`-
GCTCCCAGACACCACAAGA-3` and 5`-GCTGAGAAAATTCCCCCTTT-3` and β-actin 5`-
CTGGCTCCTAGCACCATGAAG-3` and 5`-GCCACCGATCCACACAGAGT-3`. All data were 
normalized to β-actin. Fold changes were calculated based on the comparative ∆∆Ct method. 
 
F-actin staining and microscopy 
The EC cell line was grown on rat tail collagen coated coverslips, primary ECs were grown on 
coverslips coated with commercially available collagen IV, ACs on gelatin-coated and PCs on 
uncoated coverslips until confluency. After hypoxic and ischemic exposure cells were fixed in 
4% paraformaldehyde, permeabilized in 0.1% Triton X-100 in PBS and stained for 
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filamentous actin (F-actin) using rhodamine-conjugated phalloidin (Life Technologies). Cell 
nuclei were counterstained with DAPI (4′,6-Diamidin-2-phenylindol). Pictures were taken 
using an inverted fluorescence microscope coupled to an 8-bit CCD camera (Axiocam HR, 
Carl Zeiss, Feldbach, Switzerland) and processed using ImageJ software. 
 
BrdU incorporation assay 
Cell proliferation was measured via BrdU incorporation using the colorimetric BrdU Cell 
Proliferation ELISA (Roche Diagnostics) according to the manufacturer`s instructions. Briefly, 
80-90% confluent primary ECs, ACs and PCs were subjected to OGD and O2 deprivation for 
24h and 48h. For 24h treatments BrdU reagent was added simultaneously with onset of 
OGD/O2 deprivation, whereas for 48h exposures BrdU was added 24h before the end of the 
treatment. After exposure cells were fixed for 30 min and incubated for 1.5h at 37°C with a 
peroxidase conjugated BrdU antibody (anti-BrdU-POD). After three PBS washes, peroxidase 
substrate was added and plates incubated to reach an OD405/520 of 0.4-0.5. The colorimetric 
reaction was terminated by adding 1M H2SO4 and absorbance was read at 450/620 nm using 
a Multiskan RC Microplate Photometer (Thermo Labsystems, Helsinki, Finland). 
 
MTT assay 
Cell viability was measured using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) assay as previously described [6]. Briefly all cells were cultured in 96-well plates. 
After ischemic/hypoxic exposures MTT solution (Sigma-Aldrich) was added to the medium to 
a final concentration of 0.5 mg/ml and the plates were incubated for 1h at 37°C. Subsequently 
the media was removed and cells were lysed by adding equal volume of dimethyl sulfoxide. 
Optical density was measured at 560/670 nm using a Multiskan RC Microplate Photometer 
(Thermo Labsystems) 
 
Statistical analysis 
All results are expressed as mean ± SD of three or more independent experiments. Statistical 
significance was assessed by one-way ANOVA for comparison within one group or two-way 
ANOVA for comparison between different groups using GraphPad Prism 5 software (La Jolla, 
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CA). Bonferroni`s post hoc test was used for the majority of analyses. Kolmogorov–Smirnov 
test was used to assess the qPCR data for normal distribution and subsequently the Kruskal-
Wallis non-parametric test was used to evaluate significance. A P-value <0.05 was 
considered significant. 
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RESULTS 
HIF-1α induction profiles in BBB associated cells 
Stabilization of HIF-1α protein levels in response to O2 deprivation is a central mechanism by 
which cells adapt to reduced oxygenation [25]. HIF-1α expression profiles of EC cell line, ACs 
and PCs were analyzed after exposure to hypoxia (HX, 1% O2) or near anoxia (AX, 0.2% O2) 
for up to 24h and compared to normoxic baseline expression (NX+Glc) indicated by the 
dashed line (Fig. 1A). In addition, ACs and PCs were subjected to oxygen-glucose 
deprivation (OGD) at 1% and 0.2% O2. Since the EC cell line was extremely sensitive to O2 
deprivation alone and OGD led to significant cell death, additional OGD treatment was not 
performed. In all cell types HIF-1α protein was rapidly stabilized within 2 to 6h of exposure 
and then reduced again after 24h (Fig. 1A). Notably the induction profiles differed across the 
cell types; in the EC cell line and PC HIF-1α levels peaked already at 2h whereas in ACs 
peak induction occurred at 6h. Moreover, AC and PC HIF-1α levels remained elevated after 
24h for most exposures, whereas expression levels in EC cell line had already returned to 
baseline. Importantly, the EC cell line and PCs did not show any large difference in total HIF-
1α expression between HX and AX at any time point and similarly OGD had no additional 
effect on HIF-1α stabilization in PCs compared to O2 deprivation alone. In contrast HIF-1α 
expression was clearly increased in ACs depending on the severity of insult i.e. HX versus AX 
and O2 deprivation versus OGD (Fig. 1A). To directly compare the amount of HIF-1α protein 
across the three cell types, equal amounts of protein from cells exposed to HX (Fig.1B) or AX 
(Fig.1C) in presence of glucose, were simultaneously analyzed on the same Western blot 
membrane. Intriguingly the EC cell line consistently showed 3-5 times higher HIF-1α 
expression than ACs and PCs.  
 
Differential regulation of HIF-1 and ischemia-inducible gene expression in BBB 
associated cells 
To further characterize the individual BBB cell responses to reduced oxygenation, mRNA 
expression profiles of the HIF-1 targets PHD2 (prolyl hydroxylase 2), VEGF and GLUT-1 as 
well as the hypoxia/ischemia-inducible MMP-9 [26] were analyzed by quantitative real-time 
PCR after 24 and 48h of treatment (Fig. 2). A table of the basal normoxic threshold cycles 
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(CT) for the individual cell types and analyzed genes is presented in Figure 2A. The EC cell 
line had the highest basal expression of PHD2 (CT = 26.7) compared to ACs and PCs (CT = 
28) (Fig. 2A). The cell line showed only weak 3-fold induction during O2 deprivation after 24h 
compared to the perivascular cell induction of 5 and10-fold after 24h HX and AX respectively 
(Fig. 2B). Interestingly, HX-Glc exposure led to a further pronounced increase in PHD2 
mRNA in ACs and PCs, whereas induction after 24h AX-Glc was only observed in PCs. 
Generally the PHD2 profiles after 48h were similar albeit with slightly lower induction levels 
and loss of the strong PC induction under AX-Glc.   
Different responses were observed for VEGF induction (Fig. 2C). Here PCs had the highest 
basal expression during NX (CT = 26.8) whereas ECs and ACs had values of about 29 (Fig. 
2A). After 24h of HX EC cell line showed a much stronger induction than ACs and PCs 
whereas during AX the VEGF mRNA levels were comparable between all cell types (Fig. 2C), 
again suggesting the EC cell line reacts more strongly and rapidly to O2 deprivation. Notably 
OGD induced a stronger increase in VEGF induction in ACs and PCs. Again, expression 
patterns at 48h were similar to 24h. A gradual increase in basal GLUT-1 expression was 
observed from EC cell line (CT 23) over PCs (CT 22) to ACs (CT 20; Fig. 2A). In all cell types, 
increased GLUT-1 mRNA expression correlated with increased severity and duration of the 
insult with the EC cell line displaying the strongest induction (up to 20 fold) during O2 
deprivation (Fig. 2D). Similar to our findings with VEGF, OGD was a stronger inducer of 
GLUT-1 mRNA in ACs and PCs compared to O2 deprivation alone.   
Interestingly, basal expression of MMP9 mRNA (CT 33, Fig. 2A) was very low in the EC cell 
line, unaltered after 24h of O2 deprivation and even decreased after 48h (Fig. 2E). ACs and 
PCs showed comparable severity-dependent up-regulation of MMP9 mRNA after 24 and 48h 
in presence of glucose and OGD differed only in HX-Glc where ACs showed a remarkable 
increase of MMP-9 compared to PCs.  
Notably, tests on primary ECs for basal expression of the above targets revealed similar CT 
values compared to the cell line (data not shown) highlighting similar responses of the cell 
line and primary cells. In conclusion, these findings underline the differential regulation of 
hypoxic/barrier-modulating genes in cells at the BBB and the consequence of cell-specific 
responses. 
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Injury induced actin cytoskeletal rearrangements in BBB associated cells  
Reduced oxygenation causes dynamic reorganisation of the actin cytoskeleton resulting in 
changes of cell contractility, shape and motility [27] thereby providing important information 
on cell state and activation. Thus we monitored alterations in F-actin organisation under 
different conditions, via phalloidin staining, and used such changes to make conclusions of 
the sensitivity of our cells to injury (Fig. 3). Under normoxic conditions, parallel bundles of F-
actin were observed in both the EC cell line (Fig. 3A) and primary ECs (Fig. 3B) that either 
localized to cell-cell borders and/or formed a cortical actin rim, structures crucial for 
maintaining endothelial tightness [28]. In the EC cell line, within 6h HX- and AX-mediated 
disruption of the cortical actin rim was observed and characterized by formation of stress 
fibers (white arrow) and appearance of disassembled F-actin (asterisk, Fig. 3A). After 24h of 
either treatment the cortical actin rims were completely disassembled, suggesting major 
disruption of endothelial integrity. Furthermore large inter-endothelial gaps were observed 
after 24h of AX (red arrows, Fig. 3A) and by 48h of AX a large number of cells were detached 
or dead (data not shown). Using primary ECs 24h of HX (data not shown) and AX also 
caused disorganisation of the actin cytoskeleton in the presence of glucose (asterisk, Fig. 3B) 
compared to normoxic controls. In HX-Glc, this disruption was further characterised by 
condensation of actin near the membrane (data not shown) and such observations were 
exaggerated by 24h of Ax-Glc with the formation of inter-endothelial gaps (red arrow, Fig. 3B) 
- suggesting major disruption of endothelial integrity. 
ACs and PCs have a different F-actin architecture with parallel bundles arranged across the 
cells in so called stress fibers [28]. In contrast to the EC cell line and EC primary cultures, 
both ACs and PCs proved to be very insensitive to O2 deprivation in presence of glucose as 
no alterations in F-actin organization were observed after 24h in either HX (data not shown) 
or AX (Fig. 3B) and even prolonged treatment for 48h had no effect (data not shown). 
Although HX-Glc was ineffective, AX-Glc caused appearance of condensed and disorganized 
stress fibers in both cell types after 24h of treatment (Fig. 3B) that was further pronounced 
after 48h (data not shown). Importantly, the effects on ACs were less severe as only a small 
fraction were affected and cell shape was largely conserved after 24h AX-Glc, whereas nearly 
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all PCs displayed significant F-actin disruption and chaotic cell shape changes resulting in 
very long and thin processes (Fig. 3B). These results underline our previous observation that 
both EC cell line and primary cultures are sensitive to O2 deprivation, whereas ACs and PCs 
can tolerate prolonged and severe O2 deprivation.  
 
Only ACs and PCs adapt their proliferation during O2 deprivation and ischemia  
Modulation of proliferation is a crucial factor to survive hypoxic/ischemic events [29]. 
Proliferation of primary ECs, ACs and PCs was measured using a BrdU incorporation ELISA. 
Exposure for 24h in presence or absence of glucose did not alter the proliferation of any of 
the cells (Fig. 4A) although a trend towards reduced BrdU incorporation under AX-Glc was 
measured, albeit slightly stronger in PCs (Fig. 4A). Overall AC and PC BrdU incorporation 
correlated inversely with injury severity at 48h. Indeed prolonged oxygen deprivation for 48h 
significantly reduced proliferation in both groups and substantial inhibition was observed after 
48h of OGD (Fig. 4B). Again a trend of PCs being more affected by glucose deprivation than 
ACs was apparent. Surprisingly, OGD exposure even up to 48h did little to suppress primary 
EC proliferation and similar effects were observed using the EC cell line (data not shown) 
suggesting ECs maintain their proliferative rate during injury conditions. 
 
Hypoxic/ischemic exposure differentially affects metabolic activity of BBB associated 
cells 
To assess cellular viability, we measured metabolic activity using the MTT assay that allows 
overall evaluation of the degree of cellular impairment. After 24h of HX or AX exposure, the 
metabolic activity of primary ECs was already severely reduced by about 40%, whereas ACs 
and PCs did not show any change (Fig. 5A). Although glucose withdrawal lowered the 
metabolic activity of all cells, interestingly ACs were able to somewhat maintain their activity 
even in AX-Glc, whereas the metabolic rate of ECs and PCs decreased further. Prolonged 
treatment for 48h delineated further important differences with primary ECs showing only 30% 
of initial activity during HX, whereas ACs and PCs remained largely unaffected (Fig. 5B). AX 
almost completely abolished primary EC metabolic activity whereas ACs were about 30% 
impaired. Surprisingly, during prolonged normoxic glucose withdrawal, PCs were significantly 
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less affected than ACs (or primary ECs) that lost more than 50% of their initial activity. 
However, 48h of HX-Glc gave similar degrees of AC and PC metabolic impairment that was 
accentuated in AX-Glc. Overall, primary ECs show severe and early metabolic impairment 
during O2 deprivation, even in presence of glucose, whereas both ACs and PCs are more 
responsive to glucose deprivation.  
 
Differential regulation of autophagy and cell death in BBB associated cells 
The effects seen in the MTT assay highlighted interesting differences in cell status and 
viability during different injury paradigms. However, as these assays do not allow direct 
conclusion of survival and cell death pathway activation, prominent apoptotic and autophagy 
markers were analyzed (Figs. 6-8). Since BNIP3 (BCL2/adenovirus E1B 19 kDa protein-
interacting protein 3) is a HIF-1 target gene implicated in regulation of survival promoting 
autophagy, autophagy preceding cell death, as well as apoptosis and necrosis [30] its mRNA 
and protein expression levels were analyzed by qPCR and Western blot respectively (Fig. 6). 
All three cell types expressed very low basal levels and upregulated BNIP3 transcription in 
response to O2 deprivation although their fold induction and temporal expression profiles 
differed strongly (Fig. 6A). An initial 8-10 fold increase in EC BNIP3 mRNA after 24h of HX 
and AX was measured but this was down-regulated after prolonged exposure to a 3-fold 
induction (Fig. 6A). In total contrast, PCs and particularly ACs were highly responsive 
showing a severity dependent-induction that was largely evident during HX-Glc (Fig. 6A). 
BNIP3 protein levels in the EC cell line showed a similar trend at 24h with a significant 
reduction after 48h of AX (Fig. 6B). AC and PC protein levels correlated well with the qPCR 
induction profiles and the reduced fold-change induction of BNIP3 protein in PCs compared to 
ACs was also detected.  
The consequences of increased hypoxic BNIP3 expression are controversial as both cell 
death/apoptosis promoting [30] and survival-promoting functions via induction of autophagy 
have been reported [31]. Cell death promoting functions of BNIP3 have been attributed to 
activation of Bax (Bcl-2 associated protein X) - a crucial regulator of mitochondria-dependent 
apoptosis that forms pores in the outer mitochondrial membrane allowing release of apoptotic 
proteins such as cytochrome C [32]. However, we did not observe Bax upregulation in any of 
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the cells at the mRNA (Fig. 7A) or protein level (Fig. 7B), and levels stayed constant up to 
24h of O2 deprivation and/or OGD. Furthermore prolonged treatment for 48h significantly 
reduced Bax mRNA in all cells suggesting that in our model BNIP3 does not induce Bax-
mediated signaling. BNIP3 also regulates autophagy via the activation of Beclin-1 with 
subsequent formation of LC3-II [31]. Beclin-1 participates in early autophagosome formation 
by coordinating localization of autophagic proteins and membrane trafficking [33]. 
Surprisingly, similar to Bax we did not observe increased Beclin-1 expression in any of the 
cell types during injury, but a reduction in total protein levels particularly at AX-Glc treatments 
for ACs and PCs and at all hypoxic/anoxic conditions for the EC cell line (Fig. 7B).  
To further investigate this intriguing observation, we measured levels of LC3 (microtubule-
associated protein light chain 3), a central protein of the canonical autophagy machinery and 
a down-stream target of Beclin-1 [33]. LC3 exists in 2 isoforms with LC3-I having a 
cytoplasmic localization whereas LC3-II, through conjugation with phosphatidylethanolamine 
(PE), localizes at membranes of autophagosomes and therefore its protein levels reflect the 
formation of autophagosomes [34]. In all cell types LC3-I levels were only significantly 
affected after prolonged exposure and severe insults, although PCs already showed a clear 
trend of reduced levels after 24h (Fig. 8A). In complete contrast, interesting cell-type specific 
LC3-II profiles were observed. Correlating well with the effects observed for BNIP3 
expression, the EC cell line had significantly down-regulated LC3-II mRNA and protein levels 
suggesting inhibition of autophagy during oxygen deprivation (Fig. 8B). In presence of 
glucose, ACs and PCs only showed minor changes in LC3-II mRNA during O2 deprivation 
with a mild but significant reduction at 48h (Fig. 8B). However, a glucose-dependent increase 
in LC3-II mRNA as well as protein levels was observed in both ACs and PCs (Fig. 8B). 
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DISCUSSION  
 
The BBB plays a pivotal role in supporting proper brain function and is modulated by signaling 
inputs of surrounding ACs and PCs to maintain its unique properties and function [3, 5, 19]. 
Similarly, ACs and PCs also modulate BBB tightness during hypoxic and ischemic insults, 
however, the critical factors mediating cell-specific responses as well as their functional 
consequences on BBB integrity remain a topic of debate [5-7, 12, 35]. One reason for this is 
that our understanding of individual BBB cellular component responses in terms of 
proliferation, survival, target gene induction and barrier modulation during injury is very 
limited. This study is the first to directly compare hypoxic and ischemic responses of all three 
major cells types at the BBB and to address various aspects of cellular adaptation and 
survival. We show that the BBB-associated cells differ considerably in sensitivity to hypoxic 
and ischemic insults. All our data points to the fact that endothelial cells experience O2 
deprivation much more severely than the other cell types and show a higher susceptibility. 
Two publications by Ceruti et al. and Redzic et al. recently compared survival of primary rat 
ECs, ACs and PCs under OGD (0% O2) conditions and similarly concluded that ECs are 
much more susceptible than ACs and PCs [36, 37]. Importantly, our data further suggests 
that ACs tolerate ischemic injury better than PCs. In this regard, it is noteworthy that the 
differential tolerance of these cells correlates well with the degree of O2 they experience 
under physiological conditions in vivo. Indeed, in brain capillaries an O2 content of roughly 8% 
(pO2 58 mm Hg) has been recorded [38], whereas O2 concentrations in the brain parenchyma 
are about 4% (pO2 35 mm Hg) [39] thus based on their localization ECs are accustomed to 
higher physiological O2 concentrations than PCs and ACs.  
The HIF-1 signaling pathway crucially controls hypoxic/ischemic gene expression for cell 
survival and energy metabolism but also the expression of genes regulating apoptosis and 
autophagy [18, 19]. Growing evidence suggests that the severity as well as the duration of an 
insult play a crucial role in the pathways activated [5, 6, 16, 17]. Indeed, we observed the 
more sensitive ECs stabilize 3-5 times more HIF-1α protein than the relatively resistant ACs 
and PCs, suggesting that HIF-1 induction correlates to sensitivity and may determine 
functional outcome for the different cells. In addition, rapid stabilization of HIF-1α and the 
observation that O2 deprivation severity did not alter the amount of HIF-1α stabilized in either 
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ECs or PCs. This “stereotype” maximal HIF-1α response of ECs and PCs to both mild and 
more severe insults indicates an inability to respond in a more fine-tuned manner as observed 
with ACs. The ECs also sense low O2 very rapidly and respond with a strong short lasting 
HIF-1α stabilization highlighting a greater responsiveness to O2 deprivation than the 
perivascular cells. Other studies have also shown that HIF-1α induction is strongly cell-type 
dependent. A study by Bracken et al showed that whereas some cells readily stabilize HIF-1α 
at 5% O2, others require O2 levels below 1% and that HIF-1α transactivation is also 
dependent on the severity of the hypoxic insults in different cell types [40]. As a direct 
consequence of differential HIF-1α stabilization, mRNA levels of select HIF-1 target genes 
were also cell-specifically regulated. Pronounced induction of VEGF (particularly during mild 
hypoxia) and GLUT-1 in EC compared to the other cell types correlated well with substantial 
HIF-1α stabilization, again underlining their strong responsiveness to hypoxic events. 
Interestingly, despite early HIF-1α stabilization similar to ECs, PCs did not induce VEGF 
expression in comparable strength. Indeed, reduced HIF-1α stabilization in PCs compared to 
ECs suggests the amount of HIF-1 accounts for the differential regulation of these genes. In 
contrast, PHD2 and BNIP3 induction levels were reduced in ECs compared to ACs and PCs 
although both are HIF-1 target genes, suggestive of either a cell type-specific 
regulation/activation or a severity-dependent regulation of HIF-1 target gene expression. In 
agreement it was shown previously that basal mRNA expression of hypoxia-inducible genes 
varies considerably amongst cell types and that cell-type specific induction of target genes 
occurs [41]. Similar to our conclusions, the authors correlated the amount of HIF-1α 
transcripts and protein abundance to the fold induction of hypoxia responsive genes and, 
importantly, to the susceptibility to the cells to hypoxic injury [41]. 
Since appropriate adaptation of energy metabolism is a crucial factor for surviving injurious 
events like O2 deprivation and ischemia, transcriptional regulation of the glucose transporter 
GLUT-1 was of particular interest as glucose represents the major brain energy source [42]. 
During O2 deprivation, glycolysis is crucial for ATP production and our observation of strong 
induction of GLUT-1 by EC during O2 deprivation agrees with literature showing that cerebral 
vascular glucose consumption and transport increases in response to hypoxia [43]. This 
raises the question whether ECs are more dependent on glucose uptake to feed their ATP 
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consumption during O2 deprivation than ACs and PCs. Possible reasons for this can either be 
that PCs and ACs have different energy metabolism and/or less reliance on glucose per se 
due to efficient use of alternate energy sources. Interestingly GLUT-1 induction was lower in 
ACs than PCs underlying the exceedingly versatile metabolism of ACs, i.e. the ability to 
exhibit high rates of oxidative metabolism and glycolysis, as well as the use of alternate 
energy fuels such as glycogen or glutamate [1, 44, 45]. Indeed it has long been known that 
ACs are the major glycogen store within the brain, whereas capillary endothelial cells and 
PCs have only minor reserves [46, 47]. Although further study is required, it is possible that 
PCs could employ mechanisms similar to ACs to support their resistance to hypoxic/ischemic 
injuries.  
A more global interpretation of cellular well-being was obtained by monitoring actin 
cytoskeletal architecture and metabolic activity using MTT assay - both of which emphasized 
swift alteration and impairment of ECs. Notably, rapid injury-mediated cytoskeletal 
reorganisation in ECs coincided with loss of BBB function under similar conditions in our 
previous studies [2, 6]. Additionally, EC metabolic function decreased during sole O2 
deprivation at time points when ACs and PCs remained completely unaffected. Interestingly, 
changes in cytoskeletal structure preceded metabolic suppression in all cell types but marked 
alterations in AC and PC organisation occurred only during prolonged OGD correlating well 
with cell survival and highlighting their ability to cope well with hypoxia/ischemia. Similar 
conclusions can be drawn from our BrdU proliferation assays showing that both cells adapted 
their proliferation depending on duration as well as insult severity to similar levels - likely a 
crucial response to reduce energy consumption and foster cell survival. In line with this, a 
microarray study showed that many hypoxia down-regulated genes are linked to proliferation 
[41]. In contrast increased AC proliferation during hypoxia and ischemia has also been 
reported in vivo and in vitro during acute (6h) OGD and hypoxic exposure [48-50]. We did not 
observe increased AC proliferation under any condition probably due to the more chronic time 
points selected suggesting time-dependency for the different severities. Perplexingly, despite 
being more impaired than ACs or PCs, ECs maintained their proliferation regardless of the 
severity of injury. Maintaining high proliferation, and therefore high energy consumption, 
during adverse conditions only confounds cellular adaptation and has an overall negative 
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impact on survival. Although it remains somewhat a mystery why the ECs do not 
suppress/reduce proliferation, a link with angiogenesis-mediated responses during oxygen 
deprivation could be suggested [5].  
The HIF-1 target gene BNIP3 represents a point of intersection in regulation of cell viability 
during O2 deprivation. For BNIP3, both pro-apoptotic/cell death promoting functions via Bax 
activation [30], and survival-promoting functions via autophagy-related proteins including 
Beclin-1 and LC3-II [31], have been observed. Our data suggest that BNIP3 does not 
promote Bax-mediated cell death in our model system but observations of increased LC3-II 
expression points towards BNIP3-mediated induction of autophagy. This observation is 
further supported by the resistant ACs and PCs showing strong BNIP3 expression, whereas 
the more sensitive EC cells did not. Unexpectedly, the expression profile of LC3-II did not 
match that of BNIP3, indeed we frequently observed an inverse correlation. It is notable that 
LC3-II is suggested to be a good indicator of the number of autophagosomes formed but not 
necessarily autophagic flux, as LC3-II itself is degraded during autophagosome maturation 
[34]. For this reason, strong activation of autophagy can lead to low LC3-II levels because of 
its rapid degradation, which may then be misinterpreted as a lack of autophagy. Although our 
results point towards activation of autophagic pathways by ACs and PCs to modulate their 
cell survival, additional experiments are required to fully understand the underlying 
mechanism. Nevertheless it is tempting to speculate that autophagy may represent an 
adaptive mechanism of ACs and PCs to cope with hypoxic/ischemic injury by facilitating 
removal of damaged mitochondria and regeneration of ATP by catabolism of existing 
cytoplasmic precursors [51]. It remains unclear why brain ECs do not employ similar 
mechanisms in response to hypoxia although it must be noted that hypoxia-mediated 
autophagy induction in peripheral endothelial cells has been demonstrated [52]. We 
hypothesize that absence of hypoxic BNIP3 induction underlies insufficient activation of 
survival-promoting autophagy and contributes to increased EC sensitivity to hypoxic stress.  
 
 
CONCLUSION 
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This study confirms that BBB cell types vary considerably in their sensitivity to O2 deprivation 
and ischemia. We showed that on different levels of cellular responses, ECs are highly 
susceptible to O2 deprivation whereas ACs and PCs are very tolerant to sole O2 deprivation. It 
is also noteworthy that although the EC cell line proved to be more susceptible to injury 
compared to the primary EC cells, similar overall responses and pathway signaling 
mechanisms were seen in both. Our data further establishes that perivascular cells are 
predominantly glucose responsive with ACs withstanding extreme ischemic exposure (48h, 
0.2% O2) better than PCs. Overall we propose that the physiological oxygen concentrations 
experienced by cells underpin their sensitivity to insult. Since differential susceptibility can 
directly and/or indirectly impact BBB stability, a better understanding of such causative 
relationships is crucial to combat BBB disturbance during injury. 
 
LIST OF ABBREVIATIONS 
AC: primary astrocyte, AX: near anoxia, Bax: Bcl-2 associated protein X, BBB: blood-brain 
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cell, Glc: Glucose, GLUT-1: glucose transporter 1, HIF-1: hypoxia inducible factor-1, HX: 
hypoxia, LC3: microtubule associated protein light chain 3, MMP: matrix metalloproteinase, 
OGD: oxygen-glucose deprivation, PC: primary pericyte, PHD2: prolyl hydroxylase 2, RBE4: 
rat brain microvascular endothelial cell, VEGF: vascular endothelial growth factor. 
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FIGURE LEGENDS 
Figure 1: HIF-1α induction profiles in barrier associated cells. Western blot analysis of 
HIF-1α protein expression in EC cell line, PCs and ACs exposed to HX (1% O2) and AX 
(0.2% O2) in presence or absence of glucose for up to 24h. (A) Densitometric quantification of 
HIF-1α protein expression in EC (upper left panel), PC (upper right panel) and AC (lower left 
panel). N=3; *P<0.05, **P<0.01, ***P<0.001; 1-way ANOVA compared to normoxic baseline. 
Representative comparative Western blots of HIF-1α expression in different cell types and 
their densitometric quantifications after exposure to hypoxia (B) and near anoxia (C). N=3. 
#P<0.05, ##P<0.01, ###P<0.001; 2-way ANOVA compared to EC cell line. EC: RBE4 cell line, 
AC: primary astrocyte, PC: primary pericyte, HX: hypoxia, AX: near anoxia, +Glc: with 
glucose, -Glc: without glucose.  
Figure 2: Differential regulation of HIF-1 target genes in barrier associated cells by 
quantitative PCR. (A) Table of basal normoxic expression of the analyzed genes showing 
threshold cycles (CT) ± standard deviation. mRNA expression profiles of PHD2 (B), VEGF 
(C), GLUT-1(D) and MMP-9 (E) after 24h (left panel) and 48h (right panel) of O2 deprivation 
(solid bars) and oxygen glucose deprivation (hatched bars). N=3-4. *P<0.05, **P<0.01, 
***P<0.001; 1-way ANOVA compared to normoxic baseline. §P<0.05, §§P<0.01, §§§P<0.001; 
1-way ANOVA compared to normoxia-glucose. #P<0.05, ##P<0.01, ###P<0.001; 2-way ANOVA 
comparing with (+) to without (-) glucose treatments. EC: RBE4 cell line, AC: astrocyte, PC: 
pericyte, NX: normoxia, HX: hypoxia, AX: near anoxia, +Glc: with glucose, -Glc: without 
glucose, PHD2: prolyl hydroxylase 2, VEGF: vascular endothelial growth factor, GLUT-1: 
glucose transporter 1, MMP-9: matrix metalloproteinase 9. 
 
Figure 3: O2 deprivation and ischemia induce actin cytoskeleton rearrangements in 
barrier associated cells. F-actin fibers stained with phalloidin (white) and cell nuclei with 
DAPI (blue). (A) Monolayers of EC cell line exposed to normoxia, hypoxia and near anoxia for 
6 and 24h. (B) F-actin staining of primary endothelial cell (upper panel), astrocytes (middle 
panel) and pericytes (lower panel) exposed to normoxia and near anoxia in presence or 
absence of glucose for 24h.  White arrow shows stress fiber formation; red arrows indicate 
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inter-endothelial gap formation. Asterisk highlights breakdown of F-actin resulting in 
punctuate staining. 
 
Figure 4: Adaptation of proliferation by barrier associated cells during hypoxic and 
ischemic insults. Proliferation of primary ECs, ACs and PCs was analyzed using BrdU 
incorporation assay after exposure to NX, HX and AX in presence (solid bars) and absence 
(hatched bars) of glucose for 24h (A) and 48h (B). Data values were normalized to normoxic 
baseline (NX+Glc). N=3-5. *P<0.05, **P<0.01, ***P<0.001; 1-way ANOVA compared to 
normoxia+glucose. §§§P<0.001; 1-way ANOVA compared to normoxia-glucose. #P<0.05, 
##P<0.01, ###P<0.001; 2-way ANOVA comparing + to - glucose. EC: primary endothelial cells, 
AC: primary astrocyte, PC: primary pericyte, NX: normoxia, HX: hypoxia, AX: near anoxia, 
+Glc: with glucose, -Glc: without glucose. 
 
Figure 5: Hypoxic/ischemic exposure differentially modulates metabolic activity of EC 
and perivascular cells. Viability of primary ECs, ACs and PCs was measured by MTT 
conversion after exposure to NX, HX and AX in presence (solid bars) and absence (hatched 
bars) of glucose for 24h (A) and 48h (B). Data was normalized to normoxic baseline 
(NX+Glc). N=3-5. **P<0.01, ***P<0.001; 1-way ANOVA compared to normoxia+glucose. 
§§P<0.01, §§§P<0.001; 1-way ANOVA compared to normoxia-glucose. #P<0.05, ##P<0.01, 
###P<0.001; 2-way ANOVA comparing + to - glucose. EC: primary endothelial cell, AC: 
primary astrocyte, PC: primary pericyte, NX: normoxia, HX: hypoxia, AX: near anoxia, +Glc: 
with glucose, -Glc: without glucose. 
 
Figure 6: Differential regulation of BNIP3 expression in barrier associated cells. BNIP3 
mRNA and protein expression was measured after 24h and 48h exposure to HX, AX and 
OGD and compared to NX. (A) Table of basal normoxic expression of BNIP3 showing 
threshold cycles (CT) ± standard deviation (upper panel). Lower panel BNIP3 mRNA 
expression after 24h (left) and 48h (right) of treatment. (B) Densitometric quantification of 
BNIP3 protein expression (upper panel) and representative Western blots (lower panels). 
N=4. *P<0.05, **P<0.01, ***P<0.001; 1-way ANOVA compared to normoxia+glucose. 
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§P<0.05, §§P<0.01, §§§P<0.001; 1-way ANOVA compared to normoxia-glucose. #P<0.05, 
##P<0.01, ###P<0.001; 2-way ANOVA comparing + to - glucose treatment. EC cell line: RBE4, 
AC: astrocyte, PC: pericyte, NX: normoxia, HX: hypoxia, AX: near anoxia, +Glc: with glucose, 
-Glc: without glucose. 
 
Figure 7: Prolonged and severe hypoxic/ischemic treatment decreases Bax and Beclin-
1 expression. Densitometric quantification of Bax (A) and BNIP3 (B) protein expression 
(upper panel) and representative Western Blots (lower panels) after 24h and 48h of O2 
deprivation and ischemic treatment in ECs, ACs and PCs. N=4. *P<0.05, **P<0.01, 
***P<0.001; 1-way ANOVA compared to normoxia+glucose. §P<0.05, §§P<0.01, §§§P<0.001; 
1-way ANOVA compared to normoxia-glucose. #P<0.05, ##P<0.01, ###P<0.001; 2-way ANOVA 
comparing + to - glucose treatment. EC cell line: RBE4, AC: astrocyte, PC: pericyte, NX: 
normoxia, HX: hypoxia, AX: near anoxia, +Glc: with glucose, -Glc: without glucose. 
 
Figure 8: Cell-specific regulation of LC3-II expression in barrier associated cells. 
Representative Western Blots of LC3-I (A) and LC3-II (B) expression in ECs, ACs and PCs 
are shown in lower panels, upper panels represent graphs of densitometric analysis. Cells 
were exposed to NX, HX and AX in presence and absence of glucose for 24h and 48h. N=4. 
*P<0.05, **P<0.01, ***P<0.001; 1-way ANOVA compared to normoxia+glucose. §P<0.05, 
§§P<0.01, §§§P<0.001; 1-way ANOVA compared to normoxia-glucose. #P<0.05, ##P<0.01, 
###P<0.001; 2-way ANOVA comparing + to - glucose treatment. EC cell line: RBE4, AC: 
astrocyte, PC: pericyte, NX: normoxia, HX: hypoxia, AX: near anoxia, +Glc: with glucose, -
Glc: without glucose. 
 








